[Epidemiology of mycosis and pathogen susceptibility to antimycotics].
作者信息
Sidorenko S V
出版信息
Antibiot Khimioter. 2007;52(4-5):3-11.
PMID:18464560
Abstract
摘要
相似文献
1
[Epidemiology of mycosis and pathogen susceptibility to antimycotics].
Antibiot Khimioter. 2007;52(4-5):3-11.
2
[Resistance to antimycotics: role of calcineurin and protein kinases].
Antibiot Khimioter. 2009;54(3-4):3-5.
3
Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
Future Microbiol. 2014;9(3):307-25. doi: 10.2217/fmb.13.160.
4
Current status of antifungal resistance and its impact on clinical practice.
Br J Haematol. 2014 Aug;166(4):471-84. doi: 10.1111/bjh.12896. Epub 2014 Apr 18.
5
Emerging moulds: epidemiological trends and antifungal resistance.
Mycoses. 2011 Nov;54(6):e666-78. doi: 10.1111/j.1439-0507.2011.02032.x. Epub 2011 Jun 14.
6
[How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
Pharm Unserer Zeit. 2003;32(2):124-8. doi: 10.1002/pauz.200390029.
7
42nd annual meeting of the German-Speaking Mycological Society (DMykG). Abstracts.
Mycoses. 2008 Sep;51(5):365-436. doi: 10.1111/j.1439-0507.2007.01598.x.
8
Epidemiology of antifungal susceptibility: Review of literature.
J Mycol Med. 2018 Sep;28(3):574-584. doi: 10.1016/j.mycmed.2018.04.011.
9
Heteroresistance and fungi.
Mycoses. 2017 Sep;60(9):562-568. doi: 10.1111/myc.12639. Epub 2017 Jun 28.
10
Invasive fungal infections: past achievements and challenges ahead.
Clin Microbiol Infect. 2009 Jul;15(7):599-601. doi: 10.1111/j.1469-0691.2009.02914.x.
Zotero 插件